Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The electron transport chain consists of a series of membrane-embedded protein complexes (notably NADH dehydrogenase, succinate dehydrogenase, cytochrome bc1 complex, and cytochrome c oxidase), along with mobile electron carriers such as ubiquinone and cytochrome c, located in the inner mitochondrial membrane[1][2][4][6]. These components catalyze the transfer of electrons from reduced cofactors (NADH and FADH2) to molecular oxygen, generating a proton gradient that drives ATP synthesis via ATP synthase[2][6]. Each component carries out distinct steps in oxidative phosphorylation and is fundamentally essential for cellular energy metabolism in eukaryotes (and also occurs, with complexity, in prokaryotes)[7]. The umbrella term "Electron transport chain component" does not refer to a single molecule or receptor and should be replaced with the precise molecular target(s) for any structured pharmacological or biomedical analysis.
Inhibition of electron transfer; Blocking of proton gradient generation; Interference with ATP synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Electron transport chain component.